Closed Loop Medicine, a business that makes products that combine a prescription drug with digital therapy (DTx) to allow for precise dosages and treatment, said today that the last patient in a clinical study of its incorporated precision care product is a possible answer for people with hypertension has finished taking part.
Drug and digital therapeutic mixture products are being made by Closed Loop Medicine to enhance the health of patients, assist health care providers, and help healthcare systems relocate to value-based medicine by providing personalized care at a population level.
PERSONAL COVID BP
The goal of the clinical study, called PERSONAL COVID BP, was to see if a mixture product that ties a drug to a smartphone application can help patients tailor and improve their treatment regimens for hypertension. It was very important that the study used technology that allowed people who were protecting themselves from COVID-19 to report COVID-19 infection symptoms and control their blood pressure from home, every day. The company quickly changed how it was going to keep studies going through the COVID-19 quarantine, by re-designing research to run from anywhere and by developing new technology, like the uMED decentralized clinical trial platform.
The intervention arm of the study met its goal of recruiting 200 patients. Patients were given drugs while using an app to keep an eye on their blood pressure and any possible side effects. The info from this research is being utilized to help the company devise a new product that will help people keep their blood pressure under control at a population level. High blood pressure, which is the leading factor of mortality in the western world, will be addressed by the product. Even before COVID-19 vaccines were given in 2020, high blood pressure was killing more people than both cancer and the vaccines.
The conclusions of this research paper will be shown live in Washington, D.C. from April 2 to 4. If you want to read it online, it will also be in the Journal of the American College of Cardiology (JACC).
